Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Weiqi Liao

BMgt, MMed, MRes, PhD

Data Scientist

Weiqi has an educational background in Epidemiology, Biostatistics, Population Health, and Health Services Research.

He is interested in using real-world big data and linked electronic health records (EHRs) to study disease trajectory, identify risk factors, establish prediction models, to promote early diagnosis and improve prognosis of cancer.

Current research activities

Weiqi is currently working as a lead researcher in three projects. Please click the link of each lay summary to find out the research aim and objectives for each project. 

  1. The DART project (lung cancer), lay summary for WP6 (primary care and population health) part
  2. The DeLIVER project (liver cancer), lay summary for WP6 (QResearch) part
  3. The ADEPTS project (pancreatic cancer), lay summary for WP1 (Oxford) part. This study has been published in the British Journal of General Practice, and presented at the NCRI festival (2021). This study was selected for the NCRI media programme (press release

Weiqi also contributes to two projects investigating the role of diabetes in pancreatic cancer:

  • Risk prediction tool (QPancreasD) for early diagnosis of pancreatic ductal adenocarcinoma (PDAC) among new-onset diabetes
  • Diabetes as a risk pathway towards early diagnosis of pancreatic cancer, lay summary 

Updated on 22 December 2021